Why Dose Escalation Matters for Both Medications
Do You Have To Increase Wegovy Dose: Understanding Mandatory Escalation
Yes, you absolutely have to increase your Wegovy dose according to the prescribed schedule—dose escalation cannot be skipped or accelerated. Wegovy's structured 5-stage protocol begins at 0.25mg for weeks 1-4, progressing through 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), before reaching the 2.4mg maintenance dose from week 17 onwards. This gradual escalation minimises gastrointestinal side effects whilst allowing your body to adapt to semaglutide's appetite-suppressing effects.
Mounjaro follows a different mandatory escalation pattern with 6 potential dose levels, starting at 2.5mg and potentially reaching 15mg maintenance. The key difference lies in their mechanisms: Wegovy targets GLP-1 receptors exclusively, whilst Mounjaro activates both GLP-1 and GIP receptors, explaining its higher maximum dosage. Both medications require clinical supervision to determine optimal escalation timing, and neither allows patients to remain on starter doses long-term for weight management effectiveness.
Wegovy vs Mounjaro Dose Escalation: Transparent Pricing Comparison
At EverydayMeds, we provide clear pricing for both dose escalation journeys without hidden costs. Wegovy's escalation costs £79.99 for 0.25mg starter dose, £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for 2.4mg maintenance (prices after FIRST40 discount for new customers). Our Getting Started bundles like the Intro Trio (0.25mg, 0.5mg, 1mg) cost £299.99, providing three months of escalation in one convenient order.
Mounjaro's dose escalation follows a different pricing structure reflecting its dual-hormone mechanism and higher dose strengths. Both medications qualify for our DOSE25 discount code for returning customers, and we offer 2-pen Consistency bundles for patients who need to stay at specific doses longer than the standard 4-week periods. The total escalation cost varies between medications, but both represent significant investment in long-term weight management alongside lifestyle modifications.
Clinical Evidence: Why You Must Follow Prescribed Dose Increases
The STEP clinical trials that established Wegovy's efficacy specifically tested the mandatory dose escalation protocol. In STEP 1, patients following the prescribed escalation achieved approximately 15% average weight loss at 68 weeks when combined with lifestyle interventions, compared to 2.4% with placebo. The trial protocol required all participants to progress through each dose level, demonstrating that successful outcomes depend on reaching therapeutic levels.
Mounjaro's SURMOUNT trials similarly tested structured dose escalation, though direct comparison of weight loss percentages isn't appropriate due to different trial designs and patient populations. Both medications' regulatory approval specifically requires following escalation schedules as tested in clinical trials. Attempting to maintain lower doses long-term may compromise therapeutic effectiveness for weight management.
How Wegovy's Dose Escalation Mechanism Works
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone to reduce appetite and promote satiety after smaller meals. The mandatory dose escalation allows your digestive system to gradually adapt to semaglutide's effects, reducing the likelihood of nausea, vomiting, or diarrhoea that can occur when starting GLP-1 medications. Each dose increase enhances the medication's action on brain appetite centres, progressively strengthening signals that control food intake and cravings. The 2.4mg maintenance dose represents the optimal therapeutic level for most patients, though the new 7.2mg dose approved by MHRA in January 2026 may offer additional options for some individuals. This gradual approach ensures both tolerability and effectiveness whilst your body adjusts to enhanced fullness signalling.
Streamlined Ordering Process for Both Dose Escalation Journeys
Starting your Wegovy or Mounjaro dose escalation through EverydayMeds requires just a 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our prescribers review applications within 3 working days (or 24 hours with express service) to ensure appropriate prescribing for your individual circumstances. Once approved, both medications are dispatched via next-day delivery using temperature-controlled cold-chain logistics to maintain medication integrity. Our GPhC-registered pharmacy (#9012878) ensures all prescriptions meet UK regulatory standards for prescription-only medicines. You'll receive detailed injection guidance and dose escalation schedules with your first order, plus ongoing clinical support throughout your treatment journey.
Storage and Practical Considerations: Wegovy vs Mounjaro Dose Flexibility
Wegovy offers superior storage flexibility during dose escalation, remaining stable for 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This advantage proves particularly valuable during travel or temporary accommodation changes that might affect refrigeration access. Both medications use pre-filled injection pens (Wegovy's FlexTouch vs Mounjaro's KwikPen) with clear dose windows for accurate administration. The escalation schedules require weekly injections on the same day each week, and both medications should be stored in original packaging to protect from light. Proper storage throughout the escalation period ensures consistent medication potency and therapeutic effectiveness.
Comparing Dose Escalation Flexibility: When You Have To Increase vs When You Can Adjust
The question "do you have to increase Wegovy dose" reflects patients' desire for personalised treatment approaches. Whilst both Wegovy and Mounjaro require following prescribed escalation protocols, some flexibility exists in timing—particularly if patients experience significant side effects that warrant temporary dose maintenance. Wegovy's escalation may be slowed if patients need additional time at lower doses, but cannot be accelerated beyond the tested schedule.
Mounjaro's 6-dose system potentially offers more escalation steps, which some patients find easier to tolerate than Wegovy's larger dose jumps between levels. However, both medications' effectiveness depends on reaching therapeutic maintenance doses rather than remaining on starter levels indefinitely. Your prescriber can adjust escalation timing based on individual tolerance and response, but the fundamental requirement to progress through dose levels remains essential for optimal weight management outcomes.
Making Your Choice: Both Available Through EverydayMeds
Rather than choosing between Wegovy and Mounjaro based on dose escalation alone, consider factors like mechanism of action, storage requirements, injection frequency, and your individual response to GLP-1-based medications. Both represent evidence-based approaches to weight management when combined with lifestyle modifications, and both require commitment to structured dose escalation protocols. EverydayMeds stocks both medications with transparent pricing, clinical support, and reliable supply chains to support your chosen escalation journey. Use discount code FIRST40 for new customers or DOSE25 for returning customers when ordering through our weight loss collection. Our clinical team remains available throughout your treatment to address questions about dose escalation, side effect management, and long-term weight maintenance strategies.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
